Latent Health

Based in the US, Latent Health provides clinical artificial intelligence solutions that enhance medication access and streamline prior authorization processes within healthcare systems. Latent Health, founded in 2022, operates from San Francisco, US, and focuses on integrating clinical artificial intelligence in healthcare. The company's innovative approach targets medication access challenges, ensuring efficient processes for healthcare providers. It has secured USD 80.

00 mn in Series A funding, co-led by Spark Capital and Transformation Capital, with involvement from Conviction, McKesson Ventures, General Catalyst Partners, and Y Combinator. This funding represents the total amount raised to date, reflecting a current company valuation of USD 600. 00 mn. Latent Health specializes in using clinical artificial intelligence to enhance medication access and streamline the prior authorization process within healthcare systems.

The company’s core offerings include a sophisticated platform that integrates seamlessly with Electronic Health Records (EHR), allowing healthcare providers to leverage clinical reasoning to process patient data more efficiently. This technology addresses critical challenges in medication access, particularly ensuring that patients receive essential therapies regardless of their socioeconomic status. Latent Health serves a diverse client base, including over 40 leading health systems across the United States, contributing to improved operational efficiencies and patient care. Their products are primarily utilized in major healthcare markets, focusing on transforming the medication access landscape in urban centers and regions with significant healthcare disparities.

Latent Health generates revenue through strategic partnerships and collaborations with health systems and hospitals that utilize their AI-driven medication access platform. The company operates on a subscription model, wherein healthcare organizations pay for access to their technology and services. This transactional structure supports B2B engagements, emphasizing the importance of long-term relationships with healthcare providers. Through these partnerships, Latent Health enables health systems to enhance their pharmacy programs and streamline medication delivery processes.

The financial arrangements typically reflect the value added to clients by increasing medication access and improving operational workflows, with specific pricing plans tailored to meet the diverse operational demands of each healthcare provider. In March 2026, Latent Health raised USD 80. 00 mn in Series A funding to expand its clinical reasoning engine across medication access processes by connecting EHR data, payer guidelines, and pharmacy workflows to expedite patient transitions from diagnosis to treatment. The company plans to develop new products that enhance the medication access platform, with a focus on improving user experience and operational efficiencies.

Latent Health aims to expand its services into additional geographic markets, targeting regions with significant healthcare disparities. This funding will support these initiatives, enabling further integration of their solutions within healthcare systems.